Day to day across the SYNLAB globe, our scientists are researching, publishing and collaborating with partners in scientific excellence.
Either approaching or reaching immediate clinical utility, their work lays pivotal groundwork for advancement in disease prevention, diagnostics and decision support, treatment and patient quality of life.
Each year, at the SYNLAB Congress, we recognise this commitment with our very own Medical Innovation Awards. Driven by customer needs, our 2022 awardees have contributed to medical excellence in the fields of
Turning scientific research into innovative services and products starts with the compound of an idea and the willingness to think it further, refine and transform it. This page introduces you to our award recipients, their publications—and inspirations.
SYNLAB Spain
Head of Bioinformatics Department at Sistemas Genomicos
An Update of Cutaneous Melanoma Patients Treated in Adjutancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35432383/
SYNLAB UK & Ireland
Lead Clinical Scientist, Breast and Gastric Cancer, at The Christie NHS/SYNLAB (CPP)
Combined Perioperative Lapatinib and Trastuzumab in EarlyHER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35165099/
SYNLAB UK & Ireland
Consultant Clinical Scientist, Nutristasis Unit at St Thomas' Haemostasis and Thrombosis Department St Thomas' Hospital
Vitamin B12 and Folate Markers Are Associated with Insulin Resistance During the Third Trimester of Pregnancy in South Asian Women, Living in the United Kingdom, with Gestational Diabetes and Normal Glucose Tolerance
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/34601603/
SYNLAB Italy
Researcher - SYNLAB IRCCS SDN - Napoli
A Complex Radiomic Signature in Luminal Breast Cancer from a Weighted Statistical Framework: A Pilot Study
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35204589/
SYNLAB Germany
Resident in Internal Medicine - Kath. Marienkrankenhaus gGmbH, Hamburg
Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVID-19 AntiGen (COVAG) study
National Library of Medicine –https://pubmed.ncbi.nlm.nih.gov/35386920/
SYNLAB Italy
Researcher - SYNLAB IRCCS SDN - Naples
Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35740327/
SYNLAB UK & Ireland
Director of Newborn Screening and Clinical Lead, Biochemical Sciences Scientific Director, Synnovis (A partnership between the NHS and SYNLAB UK & Ireland) Guys & St Thomas’ NHS Foundation Trust, London
Improve the harmonisation and standardisation of the results of expanded newborn screening by optimising the existing tandem mass spectrometry methods for flow injection analysis and applying a standardised calibration approach.
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35699503/
SYNLAB Germany
Biologist, SYNLAB MVZ Humangenetik Mannheim, Zentrum für Humangenetik Mannheim (ZHMA)
Combined use of serum uromodulin and eGFR to estimate mortality risk
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/34568379/
SYNLAB Germany
Specialist in microbiology, virology and infectious disease epidemiology - Medical Director, WHO Supranational Reference Laboratory for Tuberculosis, Gauting
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/34321545/
SYNLAB Italy
Researcher - SYNLAB IRCCS SDN - Napoli
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
National Library of Medicine – https://pubmed.ncbi.nlm.nih.gov/35821533/
SYNLAB Italy
Biomedical Engineer - IRCCS SDN-SYNLAB Naples
A machine learning model for supporting symptom-based referral and diagnosis of bronchitis and pneumonia in limited resource settings
ResearchGate – https://www.researchgate.net/publication/354661507
The spread of SARS-CoV-2 has become a serious challenge for public health, economy and social life in Europe and other regions of the world. To flatten the curve of new infections, not only social distancing and restrictions in public life but also fast and reliable testing plays an essential role.
SYNLAB is the leader in medical diagnostic services and specialty testing in Europe. Our mission is to provide advanced services in every diagnostic category for the benefit of you and your health. State-of-the-art technology, novel testing capabilities and an international network of medical professionals means we can offer a catalogue of more than 5000 routine and specialised tests. Fast, safe, reliable and always close by. We would like to welcome you to our world.
Forging links between medical disciplines and leading international specialists: because your success means a lot to us. Backed by SYNLAB’s team of international experts in more than 30 countries worldwide, we deliver diagnostic services of the highest calibre and make a significant contribution to interdisciplinary research.
Our expert teams and state-of-the-art diagnostic services are present in more than 30 countries on four continents. Get an insight into the history of our company and find out what drives us.
Find our job offers at our country pages and start your career with SYNLAB, the leader in medical diagnostic services and specialty testing in Europe.